Universal Ibogaine Statistics

Total Valuation

IBOGF has a market cap or net worth of 4.50 million. The enterprise value is 6.19 million.

Market Cap	4.50M
Enterprise Value	6.19M

Important Dates

The next estimated earnings date is Friday, June 27, 2025.

Earnings Date	Jun 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	308.61M
Shares Outstanding	n/a
Shares Change (YoY)	+51.81%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	280.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.43
PB Ratio	19.05
P/TBV Ratio	19.05
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.94
EV / Sales	4.48
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.35

Financial Position

The company has a current ratio of 0.49, with a Debt / Equity ratio of 7.60.

Current Ratio	0.49
Quick Ratio	0.47
Debt / Equity	7.60
Debt / EBITDA	n/a
Debt / FCF	-2.42
Interest Coverage	-7.16

Financial Efficiency

Return on equity (ROE) is -216.76% and return on invested capital (ROIC) is -18.56%.

Return on Equity (ROE)	-216.76%
Return on Assets (ROA)	-14.80%
Return on Invested Capital (ROIC)	-18.56%
Return on Capital Employed (ROCE)	-39.59%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.40
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +38.64% in the last 52 weeks. The beta is 6.50, so IBOGF's price volatility has been higher than the market average.

Beta (5Y)	6.50
52-Week Price Change	+38.64%
50-Day Moving Average	0.03
200-Day Moving Average	0.02
Relative Strength Index (RSI)	40.04
Average Volume (20 Days)	113,645

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, IBOGF had revenue of 1.31 million and -1.57 million in losses. Loss per share was -0.01.

Revenue	1.31M
Gross Profit	130,863
Operating Income	-768,439
Pretax Income	-1.57M
Net Income	-1.57M
EBITDA	-528,372
EBIT	-768,439
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 189,360 in cash and 1.80 million in debt, giving a net cash position of -1.61 million.

Cash & Cash Equivalents	189,360
Total Debt	1.80M
Net Cash	-1.61M
Net Cash Per Share	n/a
Equity (Book Value)	236,211
Book Value Per Share	0.00
Working Capital	-341,423

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -714,192 and capital expenditures -27,640, giving a free cash flow of -741,832.

Operating Cash Flow	-714,192
Capital Expenditures	-27,640
Free Cash Flow	-741,832
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 9.99%, with operating and profit margins of -58.66% and -119.86%.

Gross Margin	9.99%
Operating Margin	-58.66%
Pretax Margin	-119.86%
Profit Margin	-119.86%
EBITDA Margin	-40.33%
EBIT Margin	-58.66%
FCF Margin	n/a

Dividends & Yields

IBOGF does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-51.81%
Shareholder Yield	n/a
Earnings Yield	-34.90%
FCF Yield	-16.49%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

IBOGF has an Altman Z-Score of -10.16. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-10.16
Piotroski F-Score	n/a